Valuation: Teleflex Incorporated

Market Cap 5.64B 4.94B 4.56B 4.26B 8.02B 534B 8.2B 54.9B 21.19B 263B 21.2B 20.73B 914B P/E 2026 *
43.9x
P/E 2027 * 17.8x
Enterprise Value 5.64B 4.94B 4.56B 4.26B 8.02B 534B 8.2B 54.9B 21.19B 263B 21.2B 20.73B 914B EV / Sales 2026 *
2.47x
EV / Sales 2027 * 2.35x
Free-Float
91.41%
Yield 2026 *
1.07%
Yield 2027 * 1.08%
1 day-1.41%
1 week+1.01%
Current month-2.43%
1 month-1.61%
3 months+9.21%
6 months+3.20%
Current year+2.85%
1 week 124.77
Extreme 124.77
131.64
1 month 120.86
Extreme 120.86
136.59
Current year 100.18
Extreme 100.18
139.67
1 year 100.18
Extreme 100.18
139.67
3 years 100.18
Extreme 100.18
262.97
5 years 100.18
Extreme 100.18
428.36
10 years 100.18
Extreme 100.18
449.38
Manager TitleAgeSince
Chief Executive Officer - 2026-06-07
Director of Finance/CFO - 2025-04-01
Compliance Officer - 2017-12-31
Director TitleAgeSince
Director/Board Member 66 2008-12-31
Director/Board Member 72 2015-04-30
Director/Board Member 70 2016-09-12
Date Insider Type Main position Quantity % Market Cap.
06-07Free

Director

7,850 0.0177%
06-07Free

Chief Executive Officer

80,054 0.1808%
05-14Free

Director

5,883 0.0133%
Change 5-day change 1-year change 3-year change Capi.($)
-1.41%+1.01%+6.05%-48.14% 5.64B
-1.16%+1.09%-32.71%-16.05% 161B
-2.02%-1.85%-9.21%-10.17% 104B
-0.21%+0.02%-6.24%+46.11% 54.8B
+0.56%-3.80%+53.05%+53.64% 53.31B
-2.48%+4.82%-12.42%-42.86% 42.76B
-0.38%+11.61% - - 33.49B
-2.41%-0.76%-21.65%-46.78% 27B
+0.02%+5.56%+62.29%-7.16% 25.06B
-1.54%+3.15%-12.74%-6.83% 20.78B
Average -1.12%+5.25%+2.94%-8.69% 52.79B
Weighted average by Cap. -1.15%+4.65%-7.15%-3.94%

Financials

2026 *2027 *
Net sales 2.29B 2B 1.85B 1.73B 3.25B 216B 3.32B 22.25B 8.59B 107B 8.59B 8.4B 370B 2.4B 2.1B 1.94B 1.81B 3.41B 227B 3.49B 23.35B 9.01B 112B 9.01B 8.82B 389B
Net income -4M -3.5M -3.23M -3.02M -5.68M -378M -5.81M -38.91M -15.02M -187M -15.02M -14.69M -648M 141M 123M 114M 106M 200M 13.33B 205M 1.37B 529M 6.58B 530M 518M 22.83B
Net Debt - -
Logo Teleflex Incorporated
Teleflex Incorporated is a global provider of medical technologies. The Company offers a diverse portfolio with solutions in the therapy areas of anesthesia, emergency medicine, interventional cardiology and radiology, surgical, vascular access, and urology. It primarily designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. It operates in three segments: the Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). Its vascular access product portfolio includes Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous (bone access) systems. Its interventional product offerings consist of a portfolio of Arrow branded intra-aortic balloon pumps and catheters, GuideLiner, Turnpike and TrapLiner catheters, Pulsar-18 T3 Self-Expanding 4F Stent and Orsiro Mission Drug Eluting Stent.
Employees
15,500
Date Price Change Volume
26-06-30 US$125.28 -1.74% 55,343
26-06-29 US$127.49 -1.83% 398,964
26-06-26 US$129.86 +1.62% 602,443
26-06-25 US$127.79 +1.01% 310,305
26-06-24 US$126.51 +1.81% 267,734
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
11
Last Close Price
127.49USD
Average target price
145.89USD
Spread / Average Target
+14.43%

Quarterly revenue - Rate of surprise